TBCE
protein-codingtubulin folding cofactor E
Gene summary
Cofactor E is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
- KCS
- HRD
MANE transcript
Inheritance
ClinVar variants
Top phenotype
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~85.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0044646
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009486
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009426
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014968
Submitter: ClinGen
Progressive encephalopathy with amyotrophy and optic atrophy was first linked to biallelic variants of *TBCE* in 2016 (PMID:27666369). Six probands from 4 unrelated Southern Italian families were described as having early onset slowly progressive distal motor neuropathy resembling spinal muscular atrophy with bilateral foot drop, spasticity, cerebellar ataxia and moderate to severe intellectual developmental disorder. Brain MRIs of these patients showed cerebellar atrophy; abnormal iron deposits were also recorded in the older patients. Other reports about a recurrent non-frameshift deletion responsible for the autosomal recessive Kenny-Caffey and Sanjad-Sakati syndromes are not included as they will be lumped in another curation. *TBCE* is required for the folding of a-tubulin, a/b-tubulin dimerization, and subsequent heterodimer polymerization into microtubules, which are major components of the cytoskeleton. Structurally contains a CAP-Gly domain which mediates protein binding to a-tubulin, nine tandemly arranged leucine-rich repeat (LRR) motifs which mediate protein-protein interaction, and a ubiquitin-like domain (UBL) which is implicated in a-tubulin degradation via the proteasome. The mechanism of pathogenicity is thus far associated with two recurrent variants; the homozygous p.Ile155Asn variant or the compound heterozygous c.924del:p.Leu309Ter variant. The gene-disease relationship is also supported by experimental evidence and specifically the mouse model pmn (PMID: 12446740), which is homozygous for the missense variant TBCE:p.Trp524Gly, and shares the same phenotypic features as those observed in affected individuals. In summary, *TBCE* is associated with autosomal recessive progressive encephalopathy with amyotrophy and optic atrophy, seen in 6 individuals. This was approved by the ClinGen Brain Malformation GCEP on 02/25/2025.
Inheritance Pattern: AR
Disease ID:MONDO:0014968
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009486
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014968
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014968
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009426
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009426
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009426
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Endocrine; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Endocrine
Rationale: Individuals can present with sequelae of neonatal hypocalcemia, and prompt diagnosis and treatment can lead to correction of electrolyte abnormalities; Some individuals with multiple pituitary anomalies (eg, affecting GH, cortisol, and including features of hypogonadotropic hypogonadism have been described), and surveillance may allow early diagnosis and treatment
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TBCE variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003193.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 141 | 2 | 150 | ||
| missense | 3 | 130 | 15 | 2 | 150 | |
| nonsense | 17 | 3 | 20 | |||
| start loss | 1 | 1 | ||||
| frameshift | 25 | 6 | 5 | 36 | ||
| splice donor/acceptor (+/-2bp) | 11 | 5 | 1 | 17 | ||
| Total | 42 | 23 | 148 | 157 | 4 | 374 |
Highest pathogenic variant AF is 0.0000685139
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003184.1 | 16 | MANE Select | |
| Ensembl | ENSP00000494796.1 | 16 | MANE Select | |
| RefSeq | NP_001072983.1 | 16 | Standard | |
| RefSeq | NP_001274730.1 | 17 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Metabolism of proteins
- Protein folding
- Post-chaperonin tubulin folding pathway
Biological Process
- microtubule cytoskeleton organization
- protein folding
- post-chaperonin tubulin folding pathway
- mitotic spindle organization
Molecular Function
- protein binding
- chaperone binding
Cellular Component
- cytoplasm
- microtubule
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Tubulin-folding protein; involved in the second step of the tubulin folding pathway and in the regulation of tubulin heterodimer dissociation. Required for correct organization of microtubule cytoskeleton and mitotic splindle, and maintenance of the neuronal microtubule network. {ECO:0000269|PubMed:11847227, ECO:0000269|PubMed:27666369}.;
- Disease
- DISEASE: Hypoparathyroidism-retardation-dysmorphism syndrome (HRDS) [MIM:241410]: An autosomal recessive multisystem disorder characterized by hypoparathyroidism, intrauterine and postnatal growth retardation, psychomotor retardation, epilepsy, microcephaly, and facial dysmorphism. {ECO:0000269|PubMed:12389028}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Kenny-Caffey syndrome 1 (KCS1) [MIM:244460]: An autosomal recessive form of Kenny-Caffey syndrome, a disorder characterized by impaired skeletal development with small and dense bones, short stature, and primary hypoparathyroidism with hypocalcemia. Clinical features include cortical thickening and medullary stenosis of the tubular bones, delayed closure of fontanels, defective dentition, small eyes with hypermetropia, and frontal bossing with a triangular face. {ECO:0000269|PubMed:12389028}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Encephalopathy, progressive, with amyotrophy and optic atrophy (PEAMO) [MIM:617207]: An autosomal recessive, progressive, neurodegenerative encephalopathy with onset in infancy. Affected individuals manifest delayed psychomotor development, severe hypotonia, motor regression, spinal muscular atrophy, distal amyotrophy and weakness of all limbs, and intellectual disability of variable severity. Additional features include optic atrophy, thin corpus callosum, and cerebellar atrophy. {ECO:0000269|PubMed:27666369}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.348
Intolerance Scores
- LoFtool
- 0.901
- RVIS EVS
- 0.8
- RVIS percentile EVS
- 87.66
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- N
- Indispensability score
- 0.281
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |